|
|
||||||||
Supplements |
The US Food and Drug Administration review that provided the basis for authorizing a food-label health claim linking the risk of cancer to dietary fat intake illustrated several considerations in the use of epidemiologic data, and observational data in particular, to support dietary recommendations. The review suggested the need for clear and established criteria for judging the quality of observational human data as well as the importance of making the evaluation process for individual studies transparent and organized. The review, which provided for a claim in the absence of controlled human studies, also suggested that observational data may play a greater role when the nature of the relation to be described by a health-claim statement is broad and general rather than targeted and specific. Of particular importance was the relevance of available data to the questions inherent in showing a diet-disease relation, the need to consider the totality of the evidence, and the key role that existing authoritative reports must play in establishing the basis for relation.
Key Words: Observational data health claims dietary fat cancer epidemiologic studies notice-and-comment rule making Food and Drug Administration
This article has been cited by other articles:
![]() |
L. B. Dixon and N. D. Ernst Choose a Diet That Is Low in Saturated Fat and Cholesterol and Moderate in Total Fat: Subtle Changes to a Familiar Message J. Nutr., February 1, 2001; 131(2): 510S - 526. [Abstract] [Full Text] |
||||
![]() |
T. Byers, B. Lyle, and W. Participants Summary statement Am. J. Clinical Nutrition, June 1, 1999; 69 (6): 1365S - 1367S. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |